Sequoia is a venture capital focused on energy, financial, enterprise, healthcare, internet, and mobile startups. The firm helps a small number of daring founders build legendary companies. It spurs them to push the boundaries of what’s possible. The firm seeks to invest in all sectors with a focus on energy, financials and financial services, healthcare and healthcare services, Internet, mobile, outsourcing, and technology.

Sequoia Capital

Four Acres is a pre-seed and seed stage venture capital fund focused on software-first technology companies with a competitive moat. It seeks entrepreneurs with a technical background, business acumen, laser-like focus, and unrivaled hustle. It offers post-investment support and services that address the most pressing needs of early-stage founders, giving them the tools and relationships they need to scale their businesses.

Four Acres Capital

A pre-/seed fund investing in B2B companies across Europe

Anamcara Capital

Blue Lion is a tech venture capital fund based in Los Angeles and London, backing founders that positively advance society.  We focus on climate, health, and inclusive finance, and invest Seed (~$500k - $1m) and Series A ($1.5m - $4m) across the US & Europe.  Our unique structure allows us to continue supporting the best companies Series B+, where we have recently invested >$30m.   Our partners have backed 16 unicorns resulting in two IPOs and over a dozen M&A sales.  Nearly $425m has been invested into transformational companies such as Aetion Health, Blockchain.com, Builder.ai, Casafari, Even Healthcare, Figure, Forward Health, Glovo, Maker Studios, Omio, Opendoor, Pipe, Revolut, SoFI, and Taulia.   Founders receive an unfair advantage from our transatlantic experience.  We have held ~40 board seats on companies of >$130bn market value collectively, such as Builder.ai, Premier League, Revolut, Rathbones, British Business Bank, and the BBC.

Blue Lion

Nebular Venture Capital is an early-stage venture capital firm.

Nebular

New Enterprise Associates is a prominent venture capital firm focusing on investments in technology and healthcare startups. They help entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from the seed stage through the IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

New Enterprise Associates

Neo is a mentorship community and VC fund that brings together a diverse group of tech veterans to accelerate tomorrow's leaders.

Anterior is an AI-powered healthcare administration platform that helps approve health insurance for medical procedures. The company aims to take administrative tasks off doctors and nurses via an AI clinical co-pilot, Florence, to assist nurses and doctors in efficiently gathering the medical documentation required by insurance companies. By automating the prior authorization process, Anterior aims to reduce denial rates and expedite patient access to essential medical treatments. While their initial focus is on prior authorization automation, Anterior’s long-term plan involves expanding into other areas of medical administration.

Anterior, previously known as Co:helm, offers an AI tool that aids doctors and nurses in collating medical records required for insurance authorization. Anterior’s primary offering is Florence, a clinical co-pilot that integrates with existing workflows to enhance efficiency and accuracy in healthcare administration. The company's proprietary technology aims to reduce the administrative burden faced by health insurers in the US by ensuring that all recommendations are thoroughly reviewed and approved by human clinicians, keeping the clinician's perspective at the center.&nbsp;

Simplifying healthcare administration with intuitive tech tools

Hospital Management

Anterior nets $20m to accelerate health insurance approvals

Anterior, previously known as Co:helm, offers an AI tool that aids doctors and nurses in collating medical records required for insurance authorization. Anterior’s primary offering is Florence, a clinical co-pilot that integrates with existing workflows to enhance efficiency and accuracy in healthcare administration. The company's proprietary technology aims to reduce the administrative burden faced by health insurers in the US by ensuring that all recommendations are thoroughly reviewed and approved by human clinicians, keeping the clinician's perspective at the center.&nbsp;Key customers and partnershipsAs of June 2024, MedWatch was one of the company's earliest customers when the platform was open for waitlist.&nbsp;

Modernizing Medicine is a healthcare technology company that specializes in developing cloud-based electronic health record (EHR) systems and solutions tailored for specific medical specialties. Their flagship products, EMA and gGastro EHR, are designed to streamline clinical workflows and documentation processes, saving time for healthcare providers. These intuitive platforms incorporate built-in medical knowledge and can adapt to individual practice preferences.
Beyond EHRs, Modernizing Medicine offers an integrated suite of products and services, including practice management, revenue cycle management, endoscopy report writing, analytics, and advisory services. Their solutions aim to address the challenges of value-based care, such as population health management, quality measure reporting, and optimizing reimbursements.
Modernizing Medicine's innovative EHR architecture emphasizes speed, convenience, and adaptability, enabling doctors to complete exams efficiently. The systems can generate notes, suggest codes, and automate billing processes, reducing administrative burdens.
In November 2022, Modernizing Medicine agreed to pay USD 45 million to resolve allegations of accepting and paying illegal kickbacks, as well as causing users to report inaccurate information for federal incentive payments. The settlement addressed three marketing programs alleged to have violated the False Claims Act and the Anti-Kickback Statute.

Modernizing Medicine

Kyruus Health is a leading provider of care access solutions that connect patients with the right healthcare providers. The company's platform integrates comprehensive provider data, enabling informed decisions and seamless access to care across various touchpoints. Kyruus Health's offerings include provider search and scheduling tools, cost transparency solutions, and data management capabilities.
Kyruus Health's technology facilitates provider matching, appointment scheduling, and digital patient intake processes. The platform enhances the overall patient experience by streamlining access to care and ensuring transparency regarding provider expertise, availability, and costs. Additionally, Kyruus Health's solutions empower healthcare organizations, such as hospitals, medical groups, and health plans, to optimize provider utilization and comply with industry mandates.
Through strategic acquisitions and partnerships, Kyruus Health has expanded its network to encompass over 425,000 providers across more than 1,000 hospitals and 500 medical groups. As of 2023, the company served over 90 million health plan members from 100 different health plan brands, solidifying its position as a leading care access platform.
Key customers and partnerships
In July 2024, Kyruus Health announced a strategic partnership with XO Health, an innovative healthcare services organization designed for self-insured employers. This collaboration aimed to enhance XO Health's digital member experience by integrating Kyruus Health's provider search and cost transparency tools, ultimately creating a seamless healthcare journey for members, providers, and payers.
Furthermore, in May 2024, Kyruus Health expanded its national provider network by integrating virtual behavioral health providers, demonstrating its commitment to improving access to mental health services. This expansion added over 30,000 virtual behavioral health providers to the Kyruus Network, enabling health plans, hospitals, and medical groups to seamlessly integrate these providers into their online directories and address access gaps.
Kyruus Health also partnered with WellHive and V3 Gate to support the Veterans Health Administration (VHA), aiming to improve care for all Veterans by accelerating access to care through centralized appointment management across VHA sites.

Kyruus

AKASA is a healthcare technology company that leverages advanced generative AI and machine learning models to address administrative inefficiencies and financial challenges in the revenue cycle management (RCM) process. Their AI solutions are specifically trained on vast amounts of clinical and financial data to comprehend the nuances of the healthcare industry.
AKASA's platform is powered by large language models and generative AI capabilities akin to ChatGPT, but optimized and tailored for the healthcare domain. Their AI understands clinical context, grasps the intricate details of health systems, and is designed to integrate directly into staff workflows, enabling automation of routine tasks and improving operational efficiencies.
The company takes an "expert-in-the-loop" approach called Unified Automation, which combines machine learning with human expertise. This allows their technology to adapt to the dynamic nature of revenue cycle operations while benefiting from the judgement of AKASA's in-house team of RCM veterans with an average of over 15 years of industry experience.
AKASA's solutions aim to reduce the substantial administrative waste associated with billing and insurance communication failures, estimated at over USD 500 billion annually in the USD 4 trillion healthcare industry. By automating comprehensive and complex tasks, AKASA enables healthcare providers to reallocate staff toward patient-facing activities and enhance care delivery.

AKASA

XSOLIS is an AI technology company that offers a platform and solutions to create a more efficient healthcare system by facilitating improved communication and alignment between healthcare providers and payers. The company's flagship product, CORTEX, is an AI-driven platform that utilizes real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient. This technology aims to eliminate waste by leveraging data science, automation, transparency, and objective insights to ensure appropriate care settings.
XSOLIS's solutions streamline patient status communications, enabling providers and payers to align on medical necessity, length of stay timelines, and appropriate care levels. The platform's AI capabilities enable the creation of live clinical profiles for each patient, recognizing patterns to generate predictive analytics for determining the most suitable care setting. CORTEX reduces the administrative burden of case reviews through its proprietary Care Level Score (CLS), allowing teams to prioritize discharge planning tasks and driving optimal workflows.
By August 2022, XSOLIS achieved a three-year revenue growth of 388%, ranking No. 1795 on the 2022 Inc. 5000 list of America's fastest-growing private companies. The company reported 111% growth in its payer network and a 44% increase in hospital partnerships in the same year.

XSOLIS

Suki AI is a healthcare technology company that develops an AI-powered voice assistant, Suki Assistant, designed to help clinicians complete administrative tasks efficiently. The Suki Assistant utilizes natural language processing and generative AI to transcribe conversations between clinicians and patients into clinical notes, populating electronic health records (EHRs) with relevant data. By automating documentation, the company aims to reduce the time clinicians spend on paperwork, claiming to shrink it by as much as 72% in family medicine settings.
Suki Assistant offers multiple modes, including ambient note generation, dictation, and voice commands. The ambient mode leverages generative AI to listen to clinician-patient interactions and auto-generate clinical notes in real-time without human intervention. Clinicians can accept, reject, or edit the AI-generated content to ensure accuracy. In addition to documentation, Suki Assistant can retrieve patient information, such as medication lists and allergies, from EHRs and provide diagnosis code recommendations.
Suki Assistant is deeply integrated with major EHR systems, including Epic, Cerner, athenahealth, Elation, and Meditech, enabling bidirectional synchronization of notes and codes. The company expanded its capabilities to support inpatient care settings in October 2023, making it the first AI-powered voice solution tailored for clinicians in hospitals. Suki Assistant operates across various platforms, including iOS, Android, web, Windows, Mac, and as a Chrome extension.
In October 2023, Suki announced the acquisition of an undisclosed company to enhance its personalization features, allowing the assistant to adapt to individual user preferences and existing workflows.

Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

Companies that use GenAI as a core part of their product offering for hospital management

Offers software platforms that streamline and improve hospital operations

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Hospital Management companies use GenAI to manage and automate administrative tasks, offering a range of tech solutions designed to meet the needs of different departments and functions.

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

ANALYST_QUICK_TAKE

<div>
 
 Anterior, an AI-based healthcare company, has successfully garnered 20 million USD in a Series A funding round. New Enterprise Associates (NEA) led the round, contributing significant funds alongside major participants such as Sequoia, Neo, the co-founder of DeepMind Mustafa Suleyman, Inflection AI, and several independent angel investors. With the closure of this financial round, the company's valuation now stands at 95 million USD.
 The capital raised will be utilised by Anterior to broaden its operational reach, marking their expansion into additional medical administration sectors.
 Going under the name Co:helm in the past, Anterior's suite includes an AI tool specifically designed to aid medical professionals. Doctors and nurses can use this tool to quickly compile and collate patient medical records needed for insurance authorization. The goal of this innovative solution is to streamline this daily administrative task, leading to reduced denial rates and faster patient care.
 
</div> Analyst QuickTake: 
 With this, Anterior joins a slew of healthcare companies that raised funds this year to develop healthcare workflow solutions, including <a href="https: 
//sp-edge.com/updates/28899"> Alaffia Health </a> , which raised USD 10 million in April, <a href="https: 
//sp-edge.com/updates/27751"> Abridge </a> , which received an undisclosed amount from NVIDIA in March, and <a href="https: 
//sp-edge.com/updates/26394"> Ambience Healthcare </a> , which raised USD 70 million in February.&nbsp;

Anterior

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless